GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $314,000 | -3.4% | 7,205 | -3.6% | 0.01% | +14.3% |
| Q1 2022 | $325,000 | -16.9% | 7,472 | -15.8% | 0.01% | -12.5% |
| Q4 2021 | $391,000 | -3.0% | 8,877 | -15.8% | 0.01% | -11.1% |
| Q3 2021 | $403,000 | -2.2% | 10,540 | +2.0% | 0.01% | -10.0% |
| Q2 2021 | $412,000 | +6.5% | 10,336 | -4.6% | 0.01% | 0.0% |
| Q1 2021 | $387,000 | -7.2% | 10,836 | -4.5% | 0.01% | -9.1% |
| Q4 2020 | $417,000 | -44.4% | 11,341 | -43.1% | 0.01% | -52.2% |
| Q3 2020 | $750,000 | -24.1% | 19,928 | -17.7% | 0.02% | -30.3% |
| Q2 2020 | $988,000 | +3.5% | 24,221 | -3.9% | 0.03% | -10.8% |
| Q1 2020 | $955,000 | -26.8% | 25,202 | -9.2% | 0.04% | -9.8% |
| Q4 2019 | $1,304,000 | +9.5% | 27,758 | -0.5% | 0.04% | +2.5% |
| Q3 2019 | $1,191,000 | +7.7% | 27,908 | +0.9% | 0.04% | +5.3% |
| Q2 2019 | $1,106,000 | -9.3% | 27,648 | -5.3% | 0.04% | -11.6% |
| Q1 2019 | $1,220,000 | +4.8% | 29,184 | -4.2% | 0.04% | -6.5% |
| Q4 2018 | $1,164,000 | -7.1% | 30,451 | -2.4% | 0.05% | +7.0% |
| Q3 2018 | $1,253,000 | +6.4% | 31,194 | +6.7% | 0.04% | -2.3% |
| Q2 2018 | $1,178,000 | -1.3% | 29,234 | -4.3% | 0.04% | -2.2% |
| Q1 2018 | $1,193,000 | -23.0% | 30,533 | -30.2% | 0.04% | -18.2% |
| Q4 2017 | $1,550,000 | -20.1% | 43,713 | -8.5% | 0.06% | -23.6% |
| Q3 2017 | $1,939,000 | -6.7% | 47,752 | -0.9% | 0.07% | -8.9% |
| Q2 2017 | $2,078,000 | -0.7% | 48,202 | -2.9% | 0.08% | -3.7% |
| Q1 2017 | $2,092,000 | +6.9% | 49,618 | -2.4% | 0.08% | +2.5% |
| Q4 2016 | $1,957,000 | -18.2% | 50,824 | -8.4% | 0.08% | -19.2% |
| Q3 2016 | $2,393,000 | -5.6% | 55,491 | -5.2% | 0.10% | -6.6% |
| Q2 2016 | $2,536,000 | -5.1% | 58,525 | -11.2% | 0.11% | -7.0% |
| Q1 2016 | $2,673,000 | -4.6% | 65,926 | -5.0% | 0.11% | -5.8% |
| Q4 2015 | $2,801,000 | -24.2% | 69,417 | -27.7% | 0.12% | -28.0% |
| Q3 2015 | $3,693,000 | -20.2% | 96,040 | -13.6% | 0.17% | -13.8% |
| Q2 2015 | $4,629,000 | -10.2% | 111,132 | -0.5% | 0.20% | -12.2% |
| Q1 2015 | $5,156,000 | +5.9% | 111,724 | -1.9% | 0.22% | +6.2% |
| Q4 2014 | $4,867,000 | -15.1% | 113,876 | -8.7% | 0.21% | -17.4% |
| Q3 2014 | $5,731,000 | -13.0% | 124,663 | +1.2% | 0.25% | -13.1% |
| Q2 2014 | $6,591,000 | -3.9% | 123,237 | +0.5% | 0.29% | -9.1% |
| Q1 2014 | $6,859,000 | +12.2% | 122,620 | +7.1% | 0.32% | +11.5% |
| Q4 2013 | $6,114,000 | +7.7% | 114,515 | +1.2% | 0.29% | -1.7% |
| Q3 2013 | $5,677,000 | +0.3% | 113,162 | -0.1% | 0.29% | -4.9% |
| Q2 2013 | $5,660,000 | – | 113,259 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |